A detailed history of Arrowstreet Capital, Limited Partnership transactions in Inogen Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 103,455 shares of INGN stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103,455
Holding current value
$1.19 Million
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.67 - $12.98 $793,499 - $1.34 Million
103,455 New
103,455 $1 Million
Q2 2023

Aug 14, 2023

BUY
$10.01 - $13.86 $1.64 Million - $2.28 Million
164,147 New
164,147 $1.9 Million
Q1 2022

May 13, 2022

SELL
$28.1 - $35.25 $1.35 Million - $1.69 Million
-47,945 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$29.66 - $44.0 $1.16 Million - $1.72 Million
-39,085 Reduced 44.91%
47,945 $1.63 Million
Q3 2021

Nov 12, 2021

BUY
$43.09 - $82.26 $31,067 - $59,309
721 Added 0.84%
87,030 $3.75 Million
Q2 2021

Aug 13, 2021

SELL
$52.03 - $68.77 $1.61 Million - $2.12 Million
-30,895 Reduced 26.36%
86,309 $5.63 Million
Q1 2021

May 14, 2021

SELL
$43.96 - $55.99 $721,559 - $919,019
-16,414 Reduced 12.28%
117,204 $6.16 Million
Q4 2020

Feb 12, 2021

SELL
$27.19 - $44.68 $2.96 Million - $4.87 Million
-109,017 Reduced 44.93%
133,618 $5.97 Million
Q3 2020

Nov 12, 2020

BUY
$27.01 - $37.31 $5.16 Million - $7.13 Million
191,077 Added 370.61%
242,635 $7.04 Million
Q2 2020

Aug 12, 2020

BUY
$32.85 - $53.77 $1.69 Million - $2.77 Million
51,558 New
51,558 $1.83 Million
Q4 2018

Feb 14, 2019

SELL
$112.83 - $239.74 $1.92 Million - $4.08 Million
-17,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$189.1 - $282.92 $3.21 Million - $4.81 Million
17,000 New
17,000 $4.15 Million
Q2 2018

Aug 14, 2018

SELL
$123.8 - $192.48 $1.46 Million - $2.27 Million
-11,800 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$93.4 - $128.74 $1.1 Million - $1.52 Million
11,800
11,800 $1.41 Million

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $263M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.